Cholangiocarcinoma

Curated

in context · predicts response to

FGFR2 Fusionfusion → predicts response to Infigratinib

sensitivity

Curated

in context · predicts response to

IDH1 R132 → predicts response to Ivosidenib

sensitivity

Curated

in context · predicts response to

IDH1 Mutationother → predicts response to Ivosidenib

sensitivity

Curated

in context · predicts response to

FGFR2 Mutationother → predicts response to Infigratinib

sensitivity

Curated

in context · predicts response to

FGFR2 Fusionfusion → predicts response to Infigratinib

sensitivity

Curated

in context · predicts response to

FGFR2 Fusionfusion → predicts response to Infigratinib

sensitivity

Curated

in context · predicts response to

BRAF V600 → predicts response to Vemurafenib

sensitivity

Curated

in context · predicts response to

FGFR2 Fusionfusion → predicts response to Infigratinib

sensitivity

Curated

in context · predicts response to

FGFR2 Fusionfusion → predicts response to Infigratinib

sensitivity

Curated

in context · predicts response to

FGFR2 Mutationother → predicts response to Infigratinib

sensitivity

Curated

in context · predicts response to

ERRFI1 E384*SNV → predicts response to Erlotinib

sensitivity

Curated

in context · predicts response to

OGA Fusionfusion → predicts response to Ponatinib

sensitivity

Curated

in context · predicts response to

ERBB2 Amplificationamplification → predicts response to Pertuzumab

sensitivity

Curated

in context · predicts response to

ERBB2 Amplificationamplification → predicts response to Trastuzumab

sensitivity

Curated

Cholangiocarcinoma diagnostic of …DIAGNOSTIC_OF2 of 2
← diagnostic of	AHCYL1 Fusionfusion	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
← diagnostic of	BICC1 Fusionfusion	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →

Cholangiocarcinoma diagnostic of …DIAGNOSTIC_OF2 of 2

← diagnostic of

AHCYL1 Fusionfusion

supports

Curated

← diagnostic of

BICC1 Fusionfusion

supports

Curated

Cholangiocarcinoma associated with …ASSOCIATED_WITH15 of 16show all (up to 200)
← associated with	FGFR2	supports	A	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	IDH1	supports	A	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	FGFR2 2 source records aggregated	supports	B	Cholangiocarcinoma	2	Curated	civic	graph →
← associated with	IDH1	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	BRAF	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	AHCYL1	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	BICC1	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	FGFR2 2 source records aggregated	supports	C	Cholangiocarcinoma	2	Curated	civic	graph →
← associated with	BRAF 2 source records aggregated	supports	C	Cholangiocarcinoma	2	Curated	civic	graph →
← associated with	ERRFI1	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	OGA	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	ERBB2	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	NRG1	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	TACC3	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← associated with	AHCYL1	supports	D	Cholangiocarcinoma	1	Curated	civic	graph →

Cholangiocarcinoma associated with …ASSOCIATED_WITH15 of 16show all (up to 200)

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

2 source records aggregated

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

2 source records aggregated

supports

Curated

← associated with

2 source records aggregated

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

← associated with

supports

Curated

Cholangiocarcinoma investigated for …INVESTIGATED_FOR77 of 77show fewer
← investigated for	Infigratinibsmall_molecule	supports	A	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Ivosidenibsmall_molecule	supports	A	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Infigratinibsmall_molecule 2 source records aggregated	supports	B	Cholangiocarcinoma	2	Curated	civic	graph →
← investigated for	Ivosidenibsmall_molecule	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Vemurafenibsmall_molecule	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Pemigatinibsmall_molecule	unknown	4	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Ivosidenibsmall_molecule	unknown	4	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Infigratinibsmall_molecule	unknown	4	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Futibatinibsmall_molecule	unknown	4	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Infigratinibsmall_molecule 2 source records aggregated	supports	C	Cholangiocarcinoma	2	Curated	civic	graph →
← investigated for	Ponatinibsmall_molecule 2 source records aggregated	supports	C	Cholangiocarcinoma	2	Curated	civic	graph →
← investigated for	Erlotinibsmall_molecule	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Pertuzumabmonoclonal_antibody	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Trastuzumabmonoclonal_antibody	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Irinotecansmall_molecule	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Panitumumabmonoclonal_antibody	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Vemurafenibsmall_molecule	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Dabrafenibsmall_molecule	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Trametinibsmall_molecule	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Afatinibsmall_molecule	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Pazopanibsmall_molecule	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
← investigated for	Toripalimabmonoclonal_antibody	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Tislelizumabmonoclonal_antibody	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Tegafursmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Oxaliplatinsmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Leucovorinsmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Lenvatinibsmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Irinotecansmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Gemcitabinesmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Fluorouracilsmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Cisplatinsmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Carboplatinsmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Capecitabinesmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Bortezomibsmall_molecule	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Infigratinibsmall_molecule 2 source records aggregated	supports	D	Cholangiocarcinoma	2	Curated	civic	graph →
← investigated for	PD173074 2 source records aggregated	supports	D	Cholangiocarcinoma	2	Curated	civic	graph →
← investigated for	Yttrium-90small_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Tremelimumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Trastuzumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Trametinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Sunitinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Sorafenib Tosylatesmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Sorafenibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Sintilimabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Selumetinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Regorafenib Anhydroussmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Regorafenibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Ramucirumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Pembrolizumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Peginterferon Alfa-2bother	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Panitumumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Padeliporfinsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Paclitaxelsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Olaparibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Nivolumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Mitomycinsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Hydroxychloroquinesmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Everolimussmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Erlotinib Hydrochloridesmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Erlotinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Durvalumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Doxorubicinsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Dexamethasonesmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Derazantinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Dasatinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Copanlisibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Cetuximabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Ceritinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Camrelizumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Cabozantinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Bevacizumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Atezolizumabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Alectinibsmall_molecule	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Adebrelimabmonoclonal_antibody	unknown	2	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Tivozanibsmall_molecule	unknown	1	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Ipilimumabmonoclonal_antibody	unknown	1	Cholangiocarcinoma	1	Curated	chembl	graph →
← investigated for	Afatinibsmall_molecule	unknown	1	Cholangiocarcinoma	1	Curated	chembl	graph →

Cholangiocarcinoma investigated for …INVESTIGATED_FOR77 of 77show fewer

← investigated for

Infigratinibsmall_molecule

supports

Curated

← investigated for

Ivosidenibsmall_molecule

supports

Curated

← investigated for

Infigratinibsmall_molecule

2 source records aggregated

supports

Curated

← investigated for

Ivosidenibsmall_molecule

supports

Curated

← investigated for

Vemurafenibsmall_molecule

supports

Curated

← investigated for

Pemigatinibsmall_molecule

unknown

Curated

← investigated for

Ivosidenibsmall_molecule

unknown

Curated

← investigated for

Infigratinibsmall_molecule

unknown

Curated

← investigated for

Futibatinibsmall_molecule

unknown

Curated

← investigated for

Infigratinibsmall_molecule

2 source records aggregated

supports

Curated

← investigated for

Ponatinibsmall_molecule

2 source records aggregated

supports

Curated

← investigated for

Erlotinibsmall_molecule

supports

Curated

← investigated for

Pertuzumabmonoclonal_antibody

supports

Curated

← investigated for

Trastuzumabmonoclonal_antibody

supports

Curated

← investigated for

Irinotecansmall_molecule

supports

Curated

← investigated for

Panitumumabmonoclonal_antibody

supports

Curated

← investigated for

Vemurafenibsmall_molecule

supports

Curated

← investigated for

Dabrafenibsmall_molecule

supports

Curated

← investigated for

Trametinibsmall_molecule

supports

Curated

← investigated for

Afatinibsmall_molecule

supports

Curated

← investigated for

Pazopanibsmall_molecule

supports

Curated

← investigated for

Toripalimabmonoclonal_antibody

unknown

Curated

← investigated for

Tislelizumabmonoclonal_antibody

unknown

Curated

← investigated for

Tegafursmall_molecule

unknown

Curated

← investigated for

Oxaliplatinsmall_molecule

unknown

Curated

← investigated for

Leucovorinsmall_molecule

unknown

Curated

← investigated for

Lenvatinibsmall_molecule

unknown

Curated

← investigated for

Irinotecansmall_molecule

unknown

Curated

← investigated for

Gemcitabinesmall_molecule

unknown

Curated

← investigated for

Fluorouracilsmall_molecule

unknown

Curated

← investigated for

Cisplatinsmall_molecule

unknown

Curated

← investigated for

Carboplatinsmall_molecule

unknown

Curated

← investigated for

Capecitabinesmall_molecule

unknown

Curated

← investigated for

Bortezomibsmall_molecule

unknown

Curated

← investigated for

Infigratinibsmall_molecule

2 source records aggregated

supports

Curated

← investigated for

2 source records aggregated

supports

Curated

← investigated for

Yttrium-90small_molecule

unknown

Curated

← investigated for

Tremelimumabmonoclonal_antibody

unknown

Curated

← investigated for

Trastuzumabmonoclonal_antibody

unknown

Curated

← investigated for

Trametinibsmall_molecule

unknown

Curated

← investigated for

Sunitinibsmall_molecule

unknown

Curated

← investigated for

Sorafenib Tosylatesmall_molecule

unknown

Curated

← investigated for

Sorafenibsmall_molecule

unknown

Curated

← investigated for

Sintilimabmonoclonal_antibody

unknown

Curated

← investigated for

Selumetinibsmall_molecule

unknown

Curated

← investigated for

Regorafenib Anhydroussmall_molecule

unknown

Curated

← investigated for

Regorafenibsmall_molecule

unknown

Curated

← investigated for

Ramucirumabmonoclonal_antibody

unknown

Curated

← investigated for

Pembrolizumabmonoclonal_antibody

unknown

Curated

← investigated for

Peginterferon Alfa-2bother

unknown

Curated

← investigated for

Panitumumabmonoclonal_antibody

unknown

Curated

← investigated for

Padeliporfinsmall_molecule

unknown

Curated

← investigated for

Paclitaxelsmall_molecule

unknown

Curated

← investigated for

Olaparibsmall_molecule

unknown

Curated

← investigated for

Nivolumabmonoclonal_antibody

unknown

Curated

← investigated for

Mitomycinsmall_molecule

unknown

Curated

← investigated for

Hydroxychloroquinesmall_molecule

unknown

Curated

← investigated for

Everolimussmall_molecule

unknown

Curated

← investigated for

Erlotinib Hydrochloridesmall_molecule

unknown

Curated

← investigated for

Erlotinibsmall_molecule

unknown

Curated

← investigated for

Durvalumabmonoclonal_antibody

unknown

Curated

← investigated for

Doxorubicinsmall_molecule

unknown

Curated

← investigated for

Dexamethasonesmall_molecule

unknown

Curated

← investigated for

Derazantinibsmall_molecule

unknown

Curated

← investigated for

Dasatinibsmall_molecule

unknown

Curated

← investigated for

Copanlisibsmall_molecule

unknown

Curated

← investigated for

Cetuximabmonoclonal_antibody

unknown

Curated

← investigated for

Ceritinibsmall_molecule

unknown

Curated

← investigated for

Camrelizumabmonoclonal_antibody

unknown

Curated

← investigated for

Cabozantinibsmall_molecule

unknown

Curated

← investigated for

Bevacizumabmonoclonal_antibody

unknown

Curated

← investigated for

Atezolizumabmonoclonal_antibody

unknown

Curated

← investigated for

Alectinibsmall_molecule

unknown

Curated

← investigated for

Adebrelimabmonoclonal_antibody

unknown

Curated

← investigated for

Tivozanibsmall_molecule

unknown

Curated

← investigated for

Ipilimumabmonoclonal_antibody

unknown

Curated

← investigated for

Afatinibsmall_molecule

unknown

Curated

Cholangiocarcinoma altered in cohorts of …ALTERED_INderived15 of 139show all (up to 200)
← altered in cohorts of	HTR6 42 / 51 cases (82 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	KLHDC7A 42 / 51 cases (82 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	MRTO4 42 / 51 cases (82 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	TAS1R2 42 / 51 cases (82 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	TMCO4 42 / 51 cases (82 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	AADACL3 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	AADACL4 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ACTL8 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	AHDC1 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	AKR7A3 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ALDH4A1 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ALPL 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ARHGEF10L 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ASAP3 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →
← altered in cohorts of	ATP13A2 41 / 51 cases (80 %) · ssm · TCGA-CHOL	—	—	Cholangiocarcinoma	1	Observed	gdc	graph →

Cholangiocarcinoma altered in cohorts of …ALTERED_INderived15 of 139show all (up to 200)

← altered in cohorts of

HTR6

42 / 51 cases (82 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

KLHDC7A

42 / 51 cases (82 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

MRTO4

42 / 51 cases (82 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

TAS1R2

42 / 51 cases (82 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

TMCO4

42 / 51 cases (82 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

AADACL3

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

AADACL4

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

ACTL8

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

AHDC1

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

AKR7A3

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

ALDH4A1

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

ALPL

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

ARHGEF10L

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

ASAP3

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

← altered in cohorts of

ATP13A2

41 / 51 cases (80 %) · ssm · TCGA-CHOL

—

Observed

Cholangiocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 95show all (up to 200)
→ investigated in trials for	Gemcitabinesmall_molecule 63 trials (23 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	63	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall_molecule 49 trials (20 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	49	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal_antibody 26 trials (19 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall_molecule 23 trials (7 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall_molecule 21 trials (7 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal_antibody 19 trials (6 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall_molecule 16 trials (5 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall_molecule 16 trials (9 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 11 trials (3 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall_molecule 10 trials (4 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemigatinibsmall_molecule 10 trials (3 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall_molecule 8 trials (2 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal_antibody 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal_antibody 8 trials (7 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal_antibody 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Cholangiocarcinoma	7	Observed	clinicaltrials	graph →

Cholangiocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 95show all (up to 200)

→ investigated in trials for

Gemcitabinesmall_molecule

63 trials (23 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall_molecule

49 trials (20 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal_antibody

26 trials (19 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall_molecule

23 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall_molecule

21 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal_antibody

19 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall_molecule

16 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall_molecule

16 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

11 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall_molecule

10 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemigatinibsmall_molecule

10 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall_molecule

8 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal_antibody

8 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal_antibody

8 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal_antibody

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

Cholangiocarcinoma studied in …STUDIED_INderived10 of 758show all (up to 200)
→ studied in	NCT04645160Phase 1/Phase 2 · recruiting Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07715903Phase 1 · not yet recruiting Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Intrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06910670NA · active not recruiting Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07673341Phase 2 · recruiting [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07841574Phase 2 · recruiting HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Intrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04145141completed National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06302621Phase 1 · recruiting Pemigatinib + Afatinib in Advanced Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Cholangiocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06888063Phase 2 · recruiting Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)	—	—	Intrahepatic Cholangiocarcinoma	1	Observed	clinicaltrials	graph →

Cholangiocarcinoma studied in …STUDIED_INderived10 of 758show all (up to 200)

→ studied in

NCT04645160Phase 1/Phase 2 · recruiting

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

→ studied in

NCT05007106Phase 2 · completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

→ studied in

NCT05712356Phase 2 · completed

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

Intrahepatic Cholangiocarcinoma

→ studied in

NCT07715903Phase 1 · not yet recruiting

Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

→ studied in

NCT06910670NA · active not recruiting

Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

→ studied in

NCT07673341Phase 2 · recruiting

[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

Intrahepatic Cholangiocarcinoma

→ studied in

NCT07841574Phase 2 · recruiting

HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

→ studied in

NCT04145141completed

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

→ studied in

NCT06302621Phase 1 · recruiting

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed

Intrahepatic Cholangiocarcinoma

→ studied in

NCT06888063Phase 2 · recruiting

Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery · condition mapped ONTOLOGY_EXACT · 758 trials mapped (269 active)

—

Observed